ACW 1.41% 7.2¢ actinogen medical limited

Ann: Phase II Alzheimer's Disease Trial - results, page-58

  1. 763 Posts.
    lightbulb Created with Sketch. 141
    invmum - it is a hypothesis that cortisol impacts cognition adversely, and the results released today indicate that the hypothesis is wrong, at least at 10mg.
    The results coming out in late June are only to show that 20mg and 30mg dosages are safe not to ascertain whether the dosage has any effect on cognition. That will require a further trial down the track - probably at least 1 year away and will require further funds.
 
watchlist Created with Sketch. Add ACW (ASX) to my watchlist
(20min delay)
Last
7.2¢
Change
0.001(1.41%)
Mkt cap ! $192.5M
Open High Low Value Volume
7.2¢ 7.3¢ 7.2¢ $63.89K 879.4K

Buyers (Bids)

No. Vol. Price($)
3 955190 7.1¢
 

Sellers (Offers)

Price($) Vol. No.
7.2¢ 495767 4
View Market Depth
Last trade - 10.11am 01/08/2024 (20 minute delay) ?
ACW (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.